Logo
Login
$MAIA
$1.17 +$0.06 (5.41%) Close

$MAIA 8-K/A SEC Filings

Filed On Filing
13 Feb 2023 8-K/A: Regulation FD Disclosure

MAIA BIOTECHNOLOGY’s TelomerE-targeting Agent THIO, in combination with checkpoint inhibitor immune therapies Atezolizumab (ANTI-PD-L1) or PEMBROLIZUMAB (anti-PD-1), Demonstrated Significantly greater tumor inhibition

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans